Observation Of Chinese Medicine Applicability And Clinical Pathway Upon Acute Episode Period Of Bronchial Wheezing Syndrome (Asthma)

ObiectiveBronchial asthma (asthma) is a chronic respiratory disease, which is mainly composed of a variety of inflammatory cells, it is mainly associated with chronic airway inflammation and airway hyper responsiveness, the global initiative for asthma (GINA) of 2014 stressed that asthma is a heterogeneous disease, whose clinical manifestations are usually charactered by recurrent wheezing, shortness of breath, unexplained chest distress and chronic cough and has variability expiratory flow limitation . With the integration of the world economy and industrialization, global asthma patients have increased to 1.6 billion, The WHO reported, according to the calculation in the whole world, asthma related economic cost was significantly higher than that of HIV and tuberculosis (TB) total cost. The number of asthma patients has being up to 20 million, children asthma disease rate has up to 0.12% to 3.34%. As asthma incidence rates and mortality rate are rising year by year, it has bring heavy life pressure to the patient and bring huge burden of medical treatment to our health care system Therefore, we need to explore a "high", "low cost" treatment way, from the United States where develops the clinical path, which provides a good evidence to solve the the problem.Bronchial asthma belongs to the category of "wheezing disease" in traditional Chinese medicine, diagnosis and treatment of Chinese medicine on asthma disease has a very good clinical effect, to formulate standardized asthma (asthma) of TCM clinical pathway is the method, which combine TCM diagnosis and treatment of asthma disease and the review and norms of clinical pathway, that can improve the quality of diagnosis and treatment and reduce the medical cost, carry forward the characteristics of traditional Chinese medicine. In order to explore the feasibility and effectiveness of the asthma disease of TCM clinical pathway, the subject of respiratory department of our hospital bronchial asthma exacerbation patients were carried out in our hospital of asthma (asthma) of traditional Chinese medicine clinical pathway treatment. Statistical methods were used to evaluate the hospital of asthma (asthma) of TCM clinical pathway of traditional Chinese medicine (TCM) Climate effect, act score,hospitalization expenses, hospitalization days, characteristics of traditional Chinese medicine use and patients’ satisfaction influence, through the observation of the curative effect of asthma (asthma) of TCM clinical pathway for asthma, a preliminary assessment of our hospital of asthma (asthma) of TCM clinical pathway implementation and clinical effects of the, and to provide clinical basis for the implementation of asthma disease of TCM clinical pathway, for further to develop and validate a respiratory specialist in other diseases of TCM clinical pathway to provide reference and learn from experience.MethodsThe 60 patients in the Guangzhou Chinese medicine hospital pneumology department met the inclusion criteria, were randomly divided into two groups, the observation group and the control group, accordancing to the principle of random number table method. The observation group in our hospital asthma (bronchial asthma in TCM clinical pathway to develop treatment; the control group according to the control group treatment. Compared two groups of patients before and after treatment of TCM syndrome integral (by nimodipine method, invalid, effective, effective, clinical cure), act scores is not under control, some control, complete control), and compared the two groups the average hospitalization days, average hospitalization expenses and characteristics of traditional Chinese medicine and patient satisfaction.ResultsTable has met the inclusion criteria, a total of 60 cases of patients,in the control group 1 patient is lost to follow-up and removed, a total of 59 patients were involved in the research. The results showed that the two groups before and after the TCM syndrome score is comparable, two group effective rate reached 100%, two groups of act scores statistical comparison showed that the observation group was followed up patients before treatment act scores than of treatment after three months follow-up act scores in the observation group than in the control group. The observation group treatment can make the patients discharged with eosinophilic granulocyte percent compared with admission decreased; the observation group of average length of stay Hospital stay was significantly lower than that of the control group. The observation group of average hospitalization expenses and inspection costs were lower than those in the control group decreased significantly; observation group characteristics of traditional Chinese medicine therapy is the use of more than that in the control group, containing chinese traditional medicine, chinese patent medicine, smokeless moxibustion instrument, acupoint application, acupoint injection and Chinese medicine foment bag.ConclusionOur hospital’s implementation of TCM clinical pathway treatment of acute attack of bronchial asthma in patients with curative effect is accurate, no variation, which can reduce the number of hospitalization days and hospitalization expenses, increase the characteristics of traditional Chinese medicine treatment, increase the communication between doctors and patients, improve the quality of medical services, which can be identified by patients.